Thermo Fisher Scientific Introduces the Applied Biosystems™ InnoviGene™ Suite to Streamline Capillary Electrophoresis Biopharmaceutical and Research Workflows

WALTHAM, MASS

Image:
Overview: Workflow solutions designed for biopharmaceutical, clinical research, service provider laboratories and academic settings need streamlined and fit-for-purpose software platforms to support capillary electrophoresis (CE) applications. To help address this gap, Thermo Fisher Scientific has introduced the Applied Biosystems™ InnoviGene™ Suite*, an intuitive,  browser-based software platform to automate and optimize CE data analysis that enables 21 CFR Part 11 compliance.

 

First launching with capabilities for Sanger sequencing, InnoviGene Suite enables researchers and scientists to efficiently manage and analyze their sequencing data, ensuring reliable results and sharing customizable reports. The InnoviGene Suite initiates data exchange and analysis as soon as a run is complete, helping limit manual work that may lead to errors. Automated data tools such as quality control, confirmation, and mismatch detection can deliver improved efficiency and accuracy to optimize Sanger analysis.

 

InnoviGene software can be accessed within or outside the lab network through a browser, enabling collaboration within teams while supporting the security and privacy of data. Up to five users can access the platform at a time, connecting any number of CE instruments across a lab for increased collaboration and access to complete data.

 

 

Key Applications: Biopharmaceutical laboratories, clinical research laboratories and service providers conducting Sanger sequencing

 

Features/Benefits:
  • Enables 21 CFR Part 11 Compliance: A dedicated console (Security, Audit, e-signature) enables electronic records, users management, tracking and monitoring of processes.  
  • AI-Based Basecalling : Advanced machine learning algorithms help accurately identify nucleotide sequences, enhancing the precision and efficiency of data analysis and reducing the need for resequencing difficult samples.
  • Data Automation: Streamline and optimize your sanger data analysis leveraging automated features (quality control, confirmation, mismatch detection) for improved efficiency and accuracy.
  • Browser-Based Access: Multiple users in the lab can access the software simultaneously from any location, sharing the same data and protocols for collaborative and efficient work
  • Customizable reports: Users can tailor the presentation of data to their specific needs, thereby enhancing the clarity and relevance of the information presented.
 

Web Site:

 

www.thermofisher.com/innovigene

   
 

*The Applied Biosystems InnoviGene Suite is available for Research Use Only. Not for use in diagnostic procedures.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of more than $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

< | >